tiprankstipranks
Trending News
More News >
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Income Statement

Compare
79 Followers

BioNexus Gene Lab Corp Income Statement

Last quarter (Q1 2025), BioNexus Gene Lab Corp's total revenue was $2.14M, a decrease of -10.28% from the same quarter last year. In Q1, BioNexus Gene Lab Corp's net income was $-623.33K. See BioNexus Gene Lab Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.51M$ 9.77M$ 10.93M$ 13.36M$ 11.39M
Gross Profit
$ 1.29M$ 1.33M$ 1.26M$ 2.19M$ 1.72M
Operating Expenses
$ 2.86M$ 3.92M$ 1.55M$ 1.14M$ 446.00K
Depreciation and Amortization
$ 153.14K$ 108.42K$ 105.42K$ 108.22K$ 101.60K
EBITDA
$ -1.42M$ -2.49M$ -185.76K$ 1.16M$ 1.38M
Operating Income
$ -1.57M$ -2.59M$ -291.18K$ 1.06M$ 1.27M
Other Income/Expenses
$ -21.15K$ -13.93K$ -12.48K$ -12.97K$ -11.31K
Pretax Income
$ -1.59M$ -2.61M$ -303.66K$ 1.04M$ 1.26M
Net Income
$ -1.60M$ -2.63M$ -355.97K$ 751.57K$ 1.09M
Per Share Metrics
Basic EPS
$ -0.09$ -0.17$ -0.02$ 0.05$ 0.13
Diluted EPS
$ -0.09$ -0.17$ -0.02$ 0.05$ 0.13
Weighted Average Shares Outstanding
17.82M 1.59M 14.41M 14.27M 8.58M
Weighted Average Shares Outstanding (Diluted)
17.82M 1.59M 14.41M 14.27M 8.58M
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis